{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-114496","form_type":"8-K","ticker":"OSRH","cik":"0001840425","company_name":"OSR Holdings, Inc.","filed_at":"2025-11-25T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.745930+00:00","generated_at":"2026-05-16T17:02:08.946639+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"medium","headline":"OSR Holdings subsidiary Vaximm enters term sheet with BCM Europe for VXM01 license; $20M upfront, up to $815M milestones","bullets":["Non-binding term sheet with BCM Europe AG for exclusive global license of VXM01 oral cancer immunotherapy.","Potential $20M upfront payment plus up to $815M in clinical, regulatory, and commercial milestones.","Six-month exclusivity period for negotiations; due diligence and board approvals required.","BCM Europe is OSRH's largest shareholder; deal includes optional blockchain-based royalty mechanism (TAC tokens).","Vaximm retains IP ownership; definitive agreement would grant BCME exclusive global rights."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-114496","json":"https://secwatch.observer/filing/0001213900-25-114496.json","markdown":"https://secwatch.observer/filing/0001213900-25-114496.md","text":"https://secwatch.observer/filing/0001213900-25-114496.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1840425/000121390025114496/0001213900-25-114496-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1840425/000121390025114496/ea0267127-8k_osrhold.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T17:02:08.946639+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}